201 related articles for article (PubMed ID: 32703272)
1. Quantification of circulating microRNAs by droplet digital PCR for cancer detection.
Cirillo PDR; Margiotti K; Mesoraca A; Giorlandino C
BMC Res Notes; 2020 Jul; 13(1):351. PubMed ID: 32703272
[TBL] [Abstract][Full Text] [Related]
2. Droplet Digital PCR for Absolute Quantification of Extracellular MicroRNAs in Plasma and Serum: Quantification of the Cancer Biomarker hsa-miR-141.
Giraldez MD; Chevillet JR; Tewari M
Methods Mol Biol; 2018; 1768():459-474. PubMed ID: 29717459
[TBL] [Abstract][Full Text] [Related]
3. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.
Chen SN; Chang R; Lin LT; Chern CU; Tsai HW; Wen ZH; Li YH; Li CJ; Tsui KH
Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035447
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Circulating MicroRNAs by Droplet Digital PCR.
Ferracin M; Negrini M
Methods Mol Biol; 2018; 1768():445-457. PubMed ID: 29717458
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.
Staicu CE; Predescu DV; Rusu CM; Radu BM; Cretoiu D; Suciu N; Crețoiu SM; Voinea SC
Cells; 2020 Jan; 9(1):. PubMed ID: 31936634
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.
Berner K; Hirschfeld M; Weiß D; Rücker G; Asberger J; Ritter A; Nöthling C; Jäger M; Juhasz-Böss I; Erbes T
Arch Gynecol Obstet; 2022 Jul; 306(1):151-163. PubMed ID: 34889994
[TBL] [Abstract][Full Text] [Related]
11. Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection.
Cirillo PDR; Margiotti K; Fabiani M; Barros-Filho MC; Sparacino D; Cima A; Longo SA; Cupellaro M; Mesoraca A; Giorlandino C
PLoS One; 2021; 16(8):e0255804. PubMed ID: 34352040
[TBL] [Abstract][Full Text] [Related]
12. Absolute quantification of cell-free microRNAs in cancer patients.
Ferracin M; Lupini L; Salamon I; Saccenti E; Zanzi MV; Rocchi A; Da Ros L; Zagatti B; Musa G; Bassi C; Mangolini A; Cavallesco G; Frassoldati A; Volpato S; Carcoforo P; Hollingsworth AB; Negrini M
Oncotarget; 2015 Jun; 6(16):14545-55. PubMed ID: 26036630
[TBL] [Abstract][Full Text] [Related]
13. An Enhanced Quantitative Reverse Transcription-PCR Approach for Measuring Circulating MicroRNAs.
Tavallaie M; Khafaei M
Methods Mol Biol; 2024; 2745():227-231. PubMed ID: 38060189
[TBL] [Abstract][Full Text] [Related]
14. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.
Rapado-González Ó; López-López R; López-Cedrún JL; Triana-Martínez G; Muinelo-Romay L; Suárez-Cunqueiro MM
Cells; 2019 Dec; 8(12):. PubMed ID: 31861130
[TBL] [Abstract][Full Text] [Related]
15. Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR.
Ferracin M; Salamon I; Lupini L; Miotto E; Sabbioni S; Negrini M
J Vis Exp; 2016 Jun; (112):. PubMed ID: 27403944
[TBL] [Abstract][Full Text] [Related]
16. Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer.
Márton É; Lukács J; Penyige A; Janka E; Hegedüs L; Soltész B; Méhes G; Póka R; Nagy B; Szilágyi M
J Biotechnol; 2019 May; 297():58-65. PubMed ID: 30953675
[TBL] [Abstract][Full Text] [Related]
17. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
[TBL] [Abstract][Full Text] [Related]
19. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009
[TBL] [Abstract][Full Text] [Related]
20. The Promising Signatures of Circulating microRNA-145 in Epithelial Ovarian Cancer Patients.
Zuberi M; Mir R; Khan I; Javid J; Guru SA; Bhat M; Sumi MP; Ahmad I; Masroor M; Yadav P; Vishnubhatla S; Saxena A
Microrna; 2020; 9(1):49-57. PubMed ID: 30799804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]